Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Clobazam

A benzodiazepine synthesised in 1966 in Milan, approved from 1970 as an anxiolytic and later also used for epilepsy; it reached the United States in 2011 for Lennox-Gastaut syndrome. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It is the only 1,5-benzodiazepine to enter clinical use: the two nitrogen atoms in its ring sit at positions 1 and 5, instead of the classic positions 1 and 4.

ClobazamGo to the active ingredient →
ClobazamActive ingredientClobazamCat. No. P-C197-001CAS 22316-47-8
Clobazam-d5Isotopically labelledClobazam-d5Cat. No. P-C197-011CAS 129973-76-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.